Home
overview

SMi's 2nd Annual Conference
Wearable Injectors and Connected Devices
6 - 7 October, 2021 | London

The global wearable devices market size is expected to reach a value of $62.82 billion USD by 2025 with time dependent delivery, improved patient experience and adherence and large volume administration with minimal injection pain and being key factors driving the market.

 

With that in mind, SMi is proud to present Europe's only Wearable Injectors Conference, taking place on the 6th-7th of October 2021, in London.

 

SMi’s 2nd annual Wearable Injectors and Connected Devices conference will explore real world examples of on-body device design and development for large volume delivery while engaging in the latest digital applications for wearable devices with industry case studies from pharma thought leaders. Assess the potential of connectivity and software for medical devices in this year’s packed agenda and understand how this is aiding the use of wearable devices for clinical trials. Furthermore, key regulatory updates and guidance will be presented by regulatory, notified body and industry experts for a comprehensive outlook of this exciting and ever-growing field.

 

 

This two-day agenda offers you peer-to-peer networking with Global Device Development Managers, Senior Connectivity Engineers, Leaders in Device Data Generation, Human Factors Directors and many more.

We look forward to welcoming you to the conference in October.
 

The Wearable Injectors and Connected Devices conference will explore the growing potential of connectivity and digital health to improve patient experience and treatment while outlining the key regulatory considerations in industry with representation from regulatory and notified bodies. Assess the advances in device design and development for large volume delivery via on-body injectors and gain insights into drug/device compatibility and packaging for wearable injectors

 

The SMi Virtual Conference Platform will deliver the following benefits:

  • Live and On Demand speaker content: Get access to the latest strategies and case studies from your market place online!
  • Network with all the event attendees: Connect, see who’s attending, chat and share contact details with all online delegates, speakers and sponsors
  • Exhibit a Virtual Booth: You can pack your customized booth full of documents, videos and even show who is manning the booth during the event and hosting meetings
  • Host & Join Meetings & Socials: Join preferred speaking sessions, host you own meetings and even a virtual Networking social, with in built Zoom functionality

 

Who Should Attend
Executives, Directors, VPs, Heads, Principals, Managers of:

  • Drug-delivery developers
  • Autoinjectors
  • Device Engineering
  • Human Factors
  • Scientist
  • Product
  • Injectables
  • Packaging
  • Regulatory Affairs
  • Connectivity
  • Medical Device Data
  • Novel Product Technology
  • Smart device developers
  • Training device developers
  • Device-safety solution providers
  • Drug developers

or anyone who works with Wearable Devices/ On-Body Injectors within pharmaceutical, biotech and solution providers.
 

AstraZeneca; Bayer AG; BD; Bristol-Myers Squibb Co; Cambridge Consultants; Cambridge Design Partnership; Cambridge Innovation Limited; City of Hope National Medical Center; Covestro Deutschland AG; DCA design international; DigitalHealth; GSK; Harro Hofliger Packaging Systems Ltd; IMCD/VELOX ; Janssen Pharmaceutica NV; Johnson & Johnson; LEO Pharma A/S; Merck; MHRA; Mikron S A Boudry; Mylan; Novartis; Novartis Pharma AG; Nypro Ireland; Nypro Medical; Owen Mumford; PA Consulting Group; Pfizer; Pfizer Devices Centre of Excellence; PharmaCircle LLC; Roche; Sagentia Ltd; Sanofi ; Sanofi-Aventis Deutschland Gmbh; SCHOTT Pharmceutical Systems; Schott Schweiz AG; St George's University Hospitals NHS Foundation Trust; Team Consulting; TTP Plc; ZwickRoell GmbH & Co.KG;

Conference programme

8:30 Registration & Coffee

9:00 Co-Chairs' Opening Remarks

Tiffany McIntire

Tiffany McIntire, Senior Human Factors Engineer, Roche
View Bio

Oliver Gazeley

Oliver Gazeley, Senior Device Engineer, Roche
View Bio

9:10 Impact of Medical Device Regulation on Drug Device Combination Products

Julia Frese

Julia Frese, Director, TÜV SÜD

  • Introduction of MDR requirements 
  • Impact of MDR requirements on Drug Device Combinations 
  • Notified Body Opinion and lessons learned from first assessments
  • 9:50 A regulatory outlook for wearable connected devices

    Solange Corriol-Rohou

    Solange Corriol-Rohou, Senior Director Regulatory Affairs and Policy, EU, AstraZeneca
    View Bio

  • The use of wearable devices and real-world data – how is connectivity being used in industry 
  • An overview of current regulatory framework
  • ICI guidelines and what can we expect from the EMA
  • Data generation and future considerations
  • 10:30 Morning Coffee

    11:00 Human Factors Patch Pump Pipeline Planning

    Tiffany McIntire

    Tiffany McIntire, Senior Human Factors Engineer, Roche
    View Bio

  • Forming a platform HF strategy
  • Gather inputs: Device competitive intelligence and analysis of known use problems
  • Assessing the potential users in your pipeline
  • Leveraging existing development activities to gain additional insights
     
  • 11:40 Quantex Precision Micro-Pumps – Cutting Edge Tech Behind Drug Delivery IoT Devices of the Future

    Paul Pankhurst

    Paul Pankhurst , Founder and CEO, Quantex Arc Ltd
    View Bio

  • Far more compact, less expensive, more disposable, accurate dosing without software calibration and primary container agnostic
  • Programmable by doctors, smartphone controlled and realtime cloud data for monitoring and analysis
  • Pumps viscous fluids against high back pressures with flowrates from 1ul up to 2.4L p/h
  • Low power consumption and built in sensor for closed feedback loop for additional safety
  • Instant chat for FAQs and patient feedback
     
  • 12:20 Networking Lunch

    13:20 Considerations for early technology evaluation and selection of large-volume, on-body injectors

    Megan Heft

    Megan Heft, Senior Device Engineer, AstraZeneca
    View Bio

  • Patient-centric evaluation: incorporating early human factors evaluations to inform use case boundaries
  • Technical approaches to maximize characterization when drug product is scarce or unknown
  • Balancing use, technical, and manufacturing tradeoffs in technology selection
     
  • 14:00 Application of Wearable Sensors to measure clinical benefits in OA patients

    Germano Meier

    Germano Meier, Project Leader, Device & Digital Solutions , Novartis Pharma AG
    View Bio

  • Biomechanical Sensors Platform for OA patients monitoring
  • Development and regulatory strategy; from data collection to medical devices 
  • Potential digital end points
     
  • 14:40 Afternoon Tea

    15:10 Digital Product Development – Connecting the team as well as the device

    Chris Hurlstone

    Chris Hurlstone, Director of Engineering, Team Consulting Limited
    View Bio

  • Case Study: Illustrating how the development process for digital medical devices requires effective collaboration across a wide range of technical disciplines
  • The challenges that this can present
  • Strategies to address these challenges
     
  • 15:50 Co-Chairs' Closing Remarks and Close of Day One

    Tiffany McIntire

    Tiffany McIntire, Senior Human Factors Engineer, Roche
    View Bio

    Oliver Gazeley

    Oliver Gazeley, Senior Device Engineer, Roche
    View Bio

    8:30 Registration & Coffee

    9:00 Co-Chairs' Opening Remarks

    Tiffany McIntire

    Tiffany McIntire, Senior Human Factors Engineer, Roche
    View Bio

    Oliver Gazeley

    Oliver Gazeley, Senior Device Engineer, Roche
    View Bio

    9:10 Wearable devices regulatory considerations and the WEB-RADR project

    Phil Tregunno

    Phil Tregunno, Vigilance, Intelligence and Research Group, MHRA

  • An overview of the collaboration project with the World Health Organisation, Uppsala Monitoring Centre and the MHRA
  • WEB-RADR device reporting platform technical aspects and what this project can teach us for the future of wearable devices and connectivity
  • Software and wearable devices policy considerations

     

     

  • 9:50 MDR Implementation for On-Body Injectors

    Andreas Brand

    Andreas Brand, Managing Director, Pro3 Management, Partnering with Congenius
    View Bio

  • Integral drug/device combination products and Article 117
  • Non-integral drug/device combination products and article 13, 14, 15 and 16
  • Considerations for industry in implementing the MDR
  • How will the MDR impact the future of the drug/device combination products industry
  • 10:30 Morning Coffee

    11:00 Enhancing patient administration experience for LVIs

    Blake Green

    Blake Green, Senior Manager Regulatory Affairs, Amgen
    View Bio

  • Current wearable drug-delivery systems on the market
  • Developing injectors to improve effectivity
  • Facilitating drug administration with improved ease-of-use for patients
  • Optimising the user interface from early stage development
  • 11:40 Design strategy for connected solutions: Driving better user experience

  • Integrating patient centred device considerations into early phase development
  • Proactive portfolio strategy to enable care centered solutions 
  • Design strategy for connected solutions 
  • Connectivity as an enabler for an ideal use experience
  • Cedric Gysel

    Cedric Gysel, Manager, Healthcare Solutions Design, Johnson & Johnson
    View Bio

    12:20 Networking Lunch

    13:20 What does it take to design a good digital experience in healthcare products?

    Paul Greenhalgh

    Paul Greenhalgh, Director of Design, Team Consulting
    View Bio

  • How to design a digital product while understanding behaviours
  • How important user-centric design is for digital solutions
  • Latest design tools and techniques used to develop digital products exploring best practice in screen layouts; prompts; language and more
  • Approaches to prototyping and user testing
     
  • 14:00 Advances in wearable automatic injection devices

    Michael Kiely

    Michael Kiely, Senior Device Development Engineer, Jabil Healthcare
    View Bio

  • Challenges in large volume delivery 
  • Integrating device considerations into early phase development
  • Overview of drive mechanism options 
  • The future of on-body and bolus injectors

     

  • 14:40 Afternoon Tea

    15:10 Digital data collection within observational studies

    Barbara Stollfuss

    Barbara Stollfuss, Team Leader Data Generation, Bayer Vital GmbH

  • Challenges in digital data collection within observation studies
  • Establishing a digital study process allowing collection of medication usage data
  • An overview of case study and findings
  • 15:50 Should social distancing mean that a clinical trial must stop?

    Daniel Lewi

    Daniel Lewi, Head of Business Development, Aparito
    View Bio

  • I will discuss how decentralised trials can help overcome another pandemic like COVID-19 in relation to on going clinical trials
  • How empowering the patient and/or carer to get them recording their own health data can at least ensure that some results can come from a trial impacted by a pandemic
  • Future trials must have a contingency plan in place if trial sites are in lockdown
  • How regulators need to be willing to discuss changes to trials and protocols during a time of crisis so that a trial can continue
     
  • 16:30 Co-Chairs' Closing Remarks and Close of Day Two

    Tiffany McIntire

    Tiffany McIntire, Senior Human Factors Engineer, Roche
    View Bio

    Oliver Gazeley

    Oliver Gazeley, Senior Device Engineer, Roche
    View Bio

    +

    FEATURED SPEAKERS

    Alex Gilbert

    Alex Gilbert

    Digital Medicine, Medopad HQ
    Andreas Brand

    Andreas Brand

    Managing Director, Pro3 Management, Partnering with Congenius
    Barbara Stollfuss

    Barbara Stollfuss

    Team Leader Data Generation, Bayer Vital GmbH
    Blake Green

    Blake Green

    Senior Manager Regulatory Affairs, Amgen
    Cedric Gysel

    Cedric Gysel

    Manager, Healthcare Solutions Design, Johnson & Johnson
    Chris Hurlstone

    Chris Hurlstone

    Director of Engineering, Team Consulting Limited
    Daniel Lewi

    Daniel Lewi

    Head of Business Development, Aparito
    Digby Harris

    Digby Harris

    Global Category Manager, Digital Therapeutics, AstraZeneca UK Ltd
    Germano Meier

    Germano Meier

    Project Leader, Device & Digital Solutions , Novartis Pharma AG
    Julia Frese

    Julia Frese

    Director, TÜV SÜD
    Megan Heft

    Megan Heft

    Senior Device Engineer, AstraZeneca
    Michael Kiely

    Michael Kiely

    Senior Device Development Engineer, Jabil Healthcare
    Oliver Gazeley

    Oliver Gazeley

    Senior Device Engineer, Roche
    Paul Greenhalgh

    Paul Greenhalgh

    Director of Design, Team Consulting
    Paul Pankhurst

    Paul Pankhurst

    Founder and CEO, Quantex Arc Ltd
    Phil Tregunno

    Phil Tregunno

    Vigilance, Intelligence and Research Group, MHRA
    Solange Corriol-Rohou

    Solange Corriol-Rohou

    Senior Director Regulatory Affairs and Policy, EU, AstraZeneca
    Tiffany McIntire

    Tiffany McIntire

    Senior Human Factors Engineer, Roche

    Alex Gilbert

    Digital Medicine, Medopad HQ
    Alex Gilbert

    Alex has worked within the Digital Health industry for a number of years alongside healthcare, pharmaceutical and tech organisations. He joined Huma as one of their first employees and currently manages some of their global Life Sciences Partnerships and Digital Medicine development. His passion is the use of technology to empower and engage the patient to take control of their care.

    Andreas Brand

    Managing Director, Pro3 Management, Partnering with Congenius
    Andreas Brand

    Since 2013 Managing Director Pro3 Management GmbH

    • Provides services for MD-, IVD- & Pharma Companies
    • Project management, design control MDR/IVDR, process development
    • Organization change processes, interim management

    1999 – 2013 Roche Diabetes Care AG

    • System Project Lead for Accu-Chek® Insight
    • Co-Lead for acquisition integration Israel to DE/CN and A
    • System Project Lead for Accu-Chek® Combo (Insulin Pump System)
    • Head of Pump Development (Mechanical-, Electronic-, Software engineers)
    • Development engineer OEM projects

    1995 – 1999 Precision Implants AG (today Smith & Nephew)

    • Development Mechanical engineer

    Education

    • EMBA in International Management at Kalaidos University of Applied Sciences, Switzerland
    • Mechanical Engineer at HTL, Switzerland
    • Mechanical- Design & Construction at WIFAG
       

    Barbara Stollfuss

    Team Leader Data Generation, Bayer Vital GmbH
    Barbara Stollfuss

    Blake Green

    Senior Manager Regulatory Affairs, Amgen
    Blake Green

    Blake Green is a Regulatory Affairs Senior Manager with Amgen’s Global Medical Devices Regulatory team. Based in Cambridge UK. Blake is a Devices Regulatory lead for medicinal product/medical device combination products and co-packaged medical devices in the biopharmaceutical sector. Prior to joining Amgen, Blake had significant international experience securing multi-national market clearance for manufacturers of medical devices, medical device/medicinal product combinations, medical software, personal protective equipment, and biocides, located throughout the United States of America, European Union, North Africa, Middle East, Far East, Turkey, Israel, Australia, Canada, and Peoples Republic of China.

    Cedric Gysel

    Manager, Healthcare Solutions Design, Johnson & Johnson
    Cedric Gysel

    Cedric is a Healthcare Solutions Manager at Johnson&Johnson Design where he is responsible for Patient Centered Design initiatives supporting Janssens (Pharmaceutical Companies of J&J) R&D and Supply Chain portfolio driving better outcomes and user experience using a care centered approach. He holds a Master in Medical Device Technology from the University of Applied Science at Bern, Switzerland and has more than 10 years of experience in device development and lifecycle management.
     

    Chris Hurlstone

    Director of Engineering, Team Consulting Limited
    Chris Hurlstone

    Chris directs Team’s engineering expertise, working with the heads of Team’s development groups to ensure we deliver consistently world-class consultancy services and robust, reliable, user-focused and commercially successful device solutions. He is still very much hands-on, especially in areas such as risk management, technical audit, design verification, industrialisation and technical trouble-shooting.
    Chris has more than 20 years of experience with Team, developing technologies and devices for healthcare markets. He has successfully brought products to market in technical lead and project management roles, including inhalers, injectors and an award-winning ophthalmoscope, and in the process has worked extensively with global suppliers of manufacturing and technical expertise.
     

    Daniel Lewi

    Head of Business Development, Aparito
    Daniel Lewi

    Daniel has first-hand experience of caring for a family member with a rare disease after his daughter was diagnosed with Tay-Sachs in 2011. As the founder of the rare disease charity The Cure & Action for Tay-Sachs (CATS) Foundation, he is fully aware of the challenges that many families face when taking part in clinical trials whilst also juggling their day to day life.

    Digby Harris

    Global Category Manager, Digital Therapeutics, AstraZeneca UK Ltd
    Digby Harris

    Digby Harris is AstraZeneca’s Global Procurement lead for Digital Therapeutics and has been involved in developing Digital Therapeutics alliances for over 6 years (including connected device development). During that time Digby has also been AstraZeneca’s Global Procurement lead for drug delivery device development. Previously Digby has worked in technology licensing and research collaborations in the Oncology and Respiratory areas.

    Germano Meier

    Project Leader, Device & Digital Solutions , Novartis Pharma AG
    Germano Meier

    Germano is a Swiss-Brazilian program & project manager with 10+ years of experience in leading product development in medical and healthcare, incl. solutions for patients (combination products & patient monitoring solutions) and IVD laboratories (automated systems, assays, reagents and software for data management and results interpretation) within complex, multicultural and multidisciplinary teams.
    After his Engineering studies in Brazil, he proceeded to the Post Graduation in Project Management (DAS), Master studies in Business Administration (MBA) and Project Management Professional certification (PMI).
    Working with the Swiss pharmaceutical Novartis since 2017, he is leading one of the development initiatives embracing digital and data, and supporting a future where patients’ recruitment, trials and treatments will be enhanced by digital solutions. He will share a presentation related to the on-going exploratory work on the application of wearable sensors to measure clinical benefits in OA patients.
     

    Julia Frese

    Director, TÜV SÜD
    Julia Frese

    Megan Heft

    Senior Device Engineer, AstraZeneca
    Megan Heft

    Megan Heft is a Senior Device Engineer at AstraZeneca, where she leads device teams in the development of parenteral combination products, including early technology selection and feasibility. Megan has over ten years’ experience, with prior roles as device team lead in Combination Products R&D at Teva Pharmaceuticals and technical lead in Primary Container R&D at West Pharmaceutical Services. Megan holds a Master of Engineering in Biomedical Engineering from Cornell University and a Bachelor of Science in Biomedical Engineering from Bucknell University.

    Michael Kiely

    Senior Device Development Engineer, Jabil Healthcare
    Michael Kiely

    Michael Kiely is a Senior Device Development Engineer at Jabil Healthcare. Since joining the company in 2012, Michael has worked on the development of a large range of body worn injectors from initial concept through to design transfer and production support. He has an Honors Bachelors’ Degree in Applied Physics from Dublin City University.

    Michael is part of the Jabil Healthcare Engineering & Technology team in Ireland who have extensive experience in developing connected healthcare devices, specifically, handheld and wearable autoinjectors that deliver small to large volumes and low to high viscosity drug product.
     

    Oliver Gazeley

    Senior Device Engineer, Roche
    Oliver Gazeley

    Oliver has been working in medical devices for over 10 years, enthusiastically involved in technical innovation and leading cross-functional teams through the design process for a number of award-winning devices. After reading Engineering at the University of Cambridge, he began his career at DCA, a product development agency in the UK. He has worked on a range of medical devices such as injection pens, wearable injectors and connected devices in collaboration with such clients as Sanofi, BD and others. More recently, he has joined the Device Development team at Roche, based in Switzerland. His interests lie in the space where innovation and ingenuity meet with real patient needs.

    Paul Greenhalgh

    Director of Design, Team Consulting
    Paul Greenhalgh

    Paul Greenhalgh heads up Team’s design group, working closely with clients and colleagues to improve the user experience of medical devices through design. Paul is a passionate advocate of the importance of ‘good design’ and is involved in all stages of product development from front-end innovation to detailed design for manufacture.
    During his time at Team, Paul has led the design & project management of many innovative products including inhalers, injectors, surgical instruments, diagnostic platforms, child resistant packaging and consumer medical products. He is particularly focused on ensuring the right direction is set from the outset, that user needs are thoroughly understood and represented throughout.
    Before joining Team in 2002, Paul earned his stripes working as an in-house designer for several manufacturing companies, gaining a deep knowledge of design for injection moulding and volume manufacture and an ability to ‘see it from the other side’. He has a degree in Product Design from Central St. Martin’s College in London.
     

    Paul Pankhurst

    Founder and CEO, Quantex Arc Ltd
    Paul Pankhurst

    Dr Paul Pankhurst has been delivering award-winning tech-innovation to many of the world’s top global companies for 40 years. After graduating from RCA with a Design Engineering Degree, Paul immediately started his product innovation consultancy ‘PDD’. The team grew to 75 staff to become the largest design innovation consultancy in the UK, winning multiple annual awards, year after year. When Quantex disposable pump technology was invented, Paul recognised its huge game-changing potential for many liquid dispense solutions across sectors. After a management buy-out of PDD he founded Quantex, which now holds 74 global patents and some of the biggest corporate giants as its customers. Paul's drive to invent the next new solution is unrelenting with several exciting disruptive tech-releases scheduled in 2020-21.

    Phil Tregunno

    Vigilance, Intelligence and Research Group, MHRA
    Phil Tregunno

    Solange Corriol-Rohou

    Senior Director Regulatory Affairs and Policy, EU, AstraZeneca
    Solange Corriol-Rohou

    Solange Corriol-Rohou joined AZ R&D in 2004 and is currently Sr. Director of Regulatory Affairs & Policy for Europe. She is a pulmonologist and an immuno-allergist by training. Over the past 18 years, moving from the French Medicines Agency (formerly known as AFSSAPS) and a specialist physician position at the Hospital of Versailles (France) to the pharmaceutical industry, she has gained strategic experience in drug development for different therapy areas, such as respiratory and inflammation. She is currently leading the AZ Paediatric Work Group. Solange, in her role as the chair of the Clinical Development Expert Group at the European Federation of Pharmaceutical Industries and Associations (EFPIA), has organized jointly with the European Medicines Agency (EMA) several workshops (e.g. on Modelling & Simulation in 2011, Dose Finding/Dose Response in 2014, Paediatric Extrapolation in 2016). She has also experience working in Innovative Medicines Initiative (IMI) projects, e.g. with the PROactive consortium to develop and qualify PROs for COPD patients or as the deputy project leader of the IMI ADAPT SMART project to align all stakeholders understanding of the impact of MAPPs (Medicine Adaptive Pathways to Patients) and actively work towards MAPPs implementation. Within ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use), as the EFPIA topic leader, she has participated in the revision of the ICHE11 paediatric guideline and is currently keeping the momentum with the ICHE11A Paediatric Extrapolation Guideline which should be released in 2020.

    Tiffany McIntire

    Senior Human Factors Engineer, Roche
    Tiffany McIntire

    Tiffany McIntire has been working as a Human Factors Engineer in the pharmaceutical industry for 6 years developing delivery systems, labeling strategies, co-packed products, and new solutions. After her studies in Industrial/Organizational Psychology, she started her career at Lilly where she worked on a range of combination products including dial-and-dose insulin injectors, autoinjectors, pre-filled syringes, digital products, and nasal glucagon. While working at Lilly, she began taking Human-Computer Interaction night courses to deepen her knowledge of digital product development. After, she jumped across the pond to Germany to join a recently established device group within Boehringer Ingelheim (BI). Her core contributions in this position were deepening the team's knowledge of HF and advocating for QMS improvements. While there she worked on an AI and a PFS program, a transfer system, and an occular injection system. After her time at BI, she briefly freelanced before joining the Roche team in Basel where she is currently working.

    Sponsors and Exhibitors

    Official Media Partner

    Key Media Partners

    Supporting Media Partners

    VENUE

    Venue To Be Confirmed

    London, United Kingdom

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    Chair letter

    Download

    SPEAKER INTERVIEW - Andreas Brand, Managing Director, Pro3 Management

    Download

    Injectable Drug Delivery – Paul Greenhalgh Speaker Interview

    Download

    Infographic

    Download

    Conference brochure 2020

    Download

    Workshop programme 2020

    Download

    Past delegate list

    Download

    Full programme 2020

    Download

    Short programme 2020

    Download

    Oliver Shergold, Novartis, Past presentation

    Download

    Niall MacLoughlin,Congenius AG, Past presentation

    Download

    Michael Song, AstraZeneca, Past presentation

    Download

    Min Wei, AstraZeneca, Past presentation

    Download

    Maxime Gaillot & Andrew Warrington, Novartis, Past presentation

    Download

    Digby Harris, AstraZeneca, Past Presentation

    Download

    Bjorg K. Hunter, GSK Past presentation

    Download

    Sponsors and Exhibitors


    Quantex

    Sponsors and Exhibitors
    www.quantex-arc.com

    Quantex is the global leader in single-use pump technology enabling big-impact, game-changing fluid delivery solutions across sectors. Privately owned, Quantex holds 74 global patents commercially deployed for customised-catalogue pumps, bespoke-designed pumps and entire system designs. The pumps provide precision dosing with low power consumption enabling equipment to be more compact, less expensive and requiring zero cleaning/calibration. www.quantex-arc.com

    Media Partners


    Pharma Journalist

    Official Media Partner
    http://www.pharmajournalist.com

    Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


    ONdrugDelivery Magazine

    Official Media Partner
    http://ondrugdelivery.com

    ONdrugDelivery provides 30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. Subscribe online today to the print or free digital edition: www.ondrugdelivery.com/subscribe.

    Media Partners


    pharmaphorum

    Key Media Partners
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


    World Pharma News

    Key Media Partners
    http://www.worldpharmanews.com/



    pharmanews hq

    Key Media Partners
    http://http://pharmanewshq.com

    MedChemNet provides a unique and unparalleled platform for the medicinal chemistry community to share insights, discuss the latest research, and help move the field forward. MedChemNet covers all aspects of the drug discovery pipeline, from target identification and validation, through computer aided drug design (CADD), synthesis, screening and other biophysical techniques, to development of novel lead compounds and pre-clinical in vivo proof of concept. We also cover the design of synthetic drug delivery carriers and ADME/toxicology studies, as well as intellectual property and economic related issues. Website: Welcome to Pharma News HQ, the journal dedicated to the pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry. Pharmanewshq.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production.

    Media Partners


    Pharmacircle

    Supporting Media Partners
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Farmavita

    Supporting Media Partners
    https://farmavitar.com

    FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!


    Technology Networks

    Supporting Media Partners
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Mednous

    Supporting Media Partners
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Drug Discovery Today

    Supporting Media Partners
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.


    Pharmavision

    Supporting Media Partners
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Pharmalicensing

    Supporting Media Partners
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc


    Pharmaceutical Technology

    Supporting Media Partners
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Venue To Be Confirmed

    London
    United Kingdom

    Venue To Be Confirmed

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SMi.
    Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out